Aterian Investment Partners, a private equity firm, has purchased Contract Pharmaceuticals Limited Canada, a North American contract development and manufacturing organization (CDMO) of non-sterile liquid and semi-solid dosage forms.
Based in Mississauga, Ontario, Canada, CPL boasts relationships with global pharmaceutical companies. The company supports its customers through its FDA and Health Canada-registered facilities and sells into North America, the European Union, Japan, Australia, Mexico, Brazil and the Middle East.
“CPL represents Aterian’s thirteenth investment in the life sciences, personal care and nutrition segments,” comments Jay Taunk, principal at Aterian. “We are thrilled to support CPL and look forward to working with the management team to continue the Company’s growth trajectory.”